This is your chance to be on stage with one of Hollywood's greatest talents, the star of Diagnosis Murder, Charlie Schlatter!
Enjoy this rare and exclusive opportunity to act in an original short play written by Hollywood screenwriter and playwright, Susan Cinoman (The Goldbergs). Susan will interview you personally so she can write the role tailored to fit your personality and style! You will then enjoy 1 personal acting lesson, 3 professional rehearsals, and 3 performances in Hollywood's famed theatre festival "Adler Fest."
Charlie Schlatter is best known for his 5 years on the CBS series Diagnosis Murder starring opposite Dick Van Dyke. He’s also the voice of The Flash in Cartoon Network’s Justice league Action and is the voice of that little bee, Buzz, in the Honeynut cheerio Commercials.
As playwright, Susan Cinoman wrote for ABC television’s The Goldbergs. Plays include Fitting Rooms, Applause Books’ “Best Short Plays,” Off- Broadway: Gin and Bitters and Cinoman and Rebeck. Other productions have been seen at Ensemble Studio Theatre, Naked Angels and Circle Repertory, City Wrights and internationally, and Hungarian Rhapsody at Gulfshore Playhouse, Florida. Film work includes the screenplay, My Girlfriend at the Time (directed by Susan Seidelman). Cinoman’s new play, Guenevere, is being developed by Ivortyon Playhouse.
Susan Cinoman boasts numerous awards including: The Best Connecticut Filmmaker Award in 2009; The Best Narrative Film at New England Film and Video Festival; an Official Selection by The International Berkshire Film Festival; The Maxwell Anderson Playwrights Prize, and The Aristos Award. Susan is happy to contribute to Charlie’s fund and wishes that no one would experience the untimely passing of a loved one from this disease, as she has experienced the untimely passing of her mother and best friend, Patrick Tranter.
Notice of Updated Buyer Terms of Use
We have recently updated our Buyer Terms of Use. We encourage you to review the revised terms to ensure continued understanding and compliance. By continuing to use our platform, you acknowledge and agree to the updated terms. View the updated Terms of Use